Accessibility Menu
Xcelerate logo

Xcelerate(OTC) XCRT

Current Price$0.01
Market Cap$4.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-98%
5 Year-88%
1 Year-31%
1 Month+24%
Xcelerate last closing stock price
MetricPriceDate
Last closeUSD 0.012026-07-22
Xcelerate stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.14%USD 0.012026-07-15
1 month+23.8%USD 0.012026-06-22
3 month-13.84%USD 0.012026-04-23
Year to date+25.54%USD 0.012025-12-31
1 year-31.34%USD 0.022025-07-22
3 year-90.37%USD 0.112023-07-21
5 year-88.06%USD 0.092021-07-23
Since inception-98.43%USD 0.702005-01-25

Xcelerate Financials at a Glance

Market Cap

$4.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-$646.51K

Net Income (TTM)

-$1.13M

EPS (TTM)

$0.00

P/E Ratio

-1.69

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.01

Volume

62,574

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

May 13, 2026

XCRT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xcelerate

Xcelerate Inc. specializes in sourcing and integrating engineering expertise and patents for nascent medical technology ventures. The company applies its offerings within regulated clinical settings for rigorous evaluation and real-world implementation. Established in 1996, Xcelerate Inc. is based in Mauldin, South Carolina.

Products and Services
  • Integration of engineering expertise into medical technology
  • Deployment of technology in clinical settings for validation
  • Comprehensive approach to medical technology creation
Growth Outlook
  • Recent quarterly revenue showed a significant increase from previous periods
  • Strong gross profit margin of 51.2% indicates potential for profitability
  • Positive net income margin of 1.74% reflects operational efficiency
Financial Highlights
  • Trailing twelve months (TTM) revenue of $1.5 million
  • Quarterly net income improved to -$15,630 in Q1 2026
  • Cash and cash equivalents increased to $328,933 in Q1 2026
Xcelerate Inc. operates in the healthcare sector, focusing on medical technology. The company has shown resilience with a notable gross profit margin, indicating effective cost management and potential for future profitability. The recent quarterly financials reflect a positive trend, with a significant increase in cash reserves, which may support ongoing operations and future growth initiatives. The company's strategic focus on integrating engineering expertise into medical technology positions it well within a growing industry, making it an intriguing option for potential investors.
AI Generated • Jul 20, 2026

Industry

Healthcare Providers and Services

Employees

10

CEO

Michael F. O'Shea

Headquarters

Mauldin, SC 33071, US

XCRT Financials

Key Financial Metrics (TTM)

Gross Margin

51.22%

Operating Margin

24.49%

Net Income Margin

174.19%

Return on Equity

70.39%

Return on Capital

N/A

Return on Assets

-342.36%

Earnings Yield

-59.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

434.45M

Volume

62.57K

Avg. Volume

130.66K

Financials (TTM)

Gross Profit

-$331.13K

Operating Income

-$158.34K

EBITDA

-$115.81K

Operating Cash Flow

-$426.32K

Capital Expenditure

$5.00

Free Cash Flow

-$426.31K

Cash & ST Invst.

$328.93K

Total Debt

$1.85M

Xcelerate Performance Analysis

Xcelerate annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 1,122,085N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Xcelerate sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-17.2%
Q32025-09-30-0.7%
Q42025-12-31-422.2%
Q12026-03-31100.0%
Xcelerate annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00175.0%
20232023-12-31USD -0.01200.0%
20242024-12-31USD -0.00-63.6%
20252025-12-31USD -0.0016.7%
Xcelerate sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-100.0%
Q32025-09-30100.0%
Q42025-12-31N/A
Q12026-03-31100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$4.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$397.70K

N/A

Employees

12

N/A

Net Income

-$15.63K

+85.5%

EBITDA

-$15.63K

+79.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$328.93K

+253.2%

Total Debt

$1.85M

-9.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$1.85M

-9.0%

Return on Assets

-3.42%

N/A

Return on Invested Capital

7.69%

N/A

Free Cash Flow

-$19.13K

-167.5%

Operating Cash Flow

-$19.13K

-167.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BICXBioCorRx Inc.
$0.25+0.00%
PMEDFQscreen Ai Inc.
$0.03-3.85%
BBRRFBlueberries Medical Corp.
$0.01-49.29%
FAMDFFutura Medical plc
$0.02+76.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.23-0.07%
ONDSOndas
$7.88-0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.31-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.92+0.02%

Questions About XCRT

What is the current price of Xcelerate?

Xcelerate is trading at $0.01 per share.

What is the 52-week range for Xcelerate?

Over the past 52 weeks, Xcelerate has traded between $0.01 and $0.02.

How much debt does Xcelerate have?

As of the most recent reporting period, Xcelerate reported total debt of $1.85M.

How much cash does Xcelerate have on hand?

Xcelerate reported $328.93K in cash and cash equivalents in its most recent financial results.

What is Xcelerate’s dividend yield?

Xcelerate does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.